Health FDA Approves First D1/D5 Dopamine Agonist for Parkinson’s Disease in Decades September 28, 2026 The U.S. Food and Drug Administration approved a groundbreaking drug for Parkinson’s disease over the weekend, marking the first dopaminergic breakthrough in decades. Tavapadon, developed by pharmaceutical company AbbVie, will…